Viewing Study NCT01868568


Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2026-04-16 @ 11:09 PM
Study NCT ID: NCT01868568
Status: COMPLETED
Last Update Posted: 2015-10-22
First Post: 2013-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module